Interius BioTherapeutics, Inc.
Biotechnology company · Philadelphia, Pennsylvania, United States
Interius BioTherapeutics, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $51 million sold in a notice filed in 2024.
Interius BioTherapeutics at a glance
What does Interius BioTherapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $51.4 million sold (2024).
Frequently asked questions about Interius BioTherapeutics
Where is Interius BioTherapeutics headquartered?
Interius BioTherapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does Interius BioTherapeutics do?
Interius BioTherapeutics, Inc. is a biotechnology company.
When was Interius BioTherapeutics founded?
The earliest incorporation on record for Interius BioTherapeutics, Inc. is in 2019, according to public company registers.
Similar companies
- Spark Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Cabaletta Bio, Inc.Philadelphia, Pennsylvania, United States
- Passage BIO, Inc.Philadelphia, Pennsylvania, United States
- ZSX Medical, LLCPhiladelphia, Pennsylvania, United States
- Enterin, Inc.Philadelphia, Pennsylvania, United States
- Century Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- PolyCore Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Five Eleven Pharma Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences